Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Capital Lease Obligations
$2.30M
Quarterly · Period ending: · USD
LCTX Capital Lease Obligations
Latest reported$2.30Mperiod ending
Latest reported$2.30Mperiod ending
LCTX Quarterly Capital Lease Obligations ($0.00 → $2.30M)
Quarterly capital lease obligations
High-resolution chart · PNG
LCTX capital lease obligations history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Lease Obligations (USD) |
|---|---|
| 2,299,000 | |
| 1,529,000 | |
| 2,419,000 | |
| 2,621,000 | |
| 2,154,000 | |
| 2,244,000 | |
| 2,514,000 | |
| 2,750,000 | |
| 2,951,000 | |
| 3,254,000 | |
| 2,952,000 | |
| 3,080,000 | |
| 3,404,000 | |
| 3,638,000 | |
| 3,896,000 | |
| 2,800,000 | |
| 2,100,000 | |
| 2,557,000 | |
| 2,802,000 | |
| 2,717,000 | |
| 2,901,000 | |
| 3,029,000 | |
| 3,302,000 | |
| 2,317,000 | |
| 3,338,000 | |
| 3,593,000 | |
| 3,945,000 | |
| 5,312,000 | |
| 4,874,000 | |
| 5,073,000 | |
| 2,195,000 | |
| 341,000 | |
| 341,000 | |
| 344,000 | |
| 1,363,000 | |
| 1,257,000 | |
| 1,301,000 | |
| 1,344,000 | |
| 1,898,000 | |
| 1,610,000 | |
| 1,681,000 | |
| 5,462,000 | |
| 4,464,000 | |
| 4,135,000 | |
| 3,392,000 | |
| 635,777 | |
| 467,000 | |
| 102,463 | |
| 115,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |